Otsuka Pharmaceutical Factory

News Release

November 13, 2024: Otsuka Pharmaceutical Factory and ICU Medical Announce the Establishment of Joint Venture
October 29, 2024: Supply of Renewable Energy to Business Partners -Towards Achieving Carbon Neutrality Throughout Our Supply Chain-
September 30, 2024: EN Otsuka Pharmaceutical Co., Ltd. obtains marketing approval of "ENOSOLID Semi Solid for Enteral Use"
September 24, 2024: Otsuka Pharmaceutical Factory obtains marketing approval of "KIDPAREN Injection," the amino acid, glucose, electrolyte, fat, and multivitamin injection for high calorie parenteral nutrition of patients with chronic kidney disease
September 10, 2024: Otsuka Pharmaceutical Factory launches additional OS-1 Jelly Apple Flavor 200 g to the Oral Rehydration Solution OS-1 series
August 26, 2024: Otsuka Pharmaceutical Factory to Start Distributing an App "Nurtal" to Visualize Administration of Nutrition and Support Nutrition Management by Healthcare Professionals
July 29, 2024: Otsuka Pharmaceutical Factory to Build a New Factory "MP-PS" for Stable Supply of Prefilled Syringes

Link